RK-20448
Product Specifications
Product Name Alternative
YH439,Ticalopride,(±)-Norcisapride; rel-Ticalopride
UNSPSC Description
RK-20448 is an ATP-competitive inhibitor of Lck, Src, KDR/VEGF2R and Tie-2 with IC50 values of 0.24, 1.19, 10.74 and 5.85 µM, respectively. RK-20448 also inhibits BLK, Csk, Fyn and Lyn with IC50 values of 0.37, 4.27, 2.03 and 0.43 µM, respectively. RK-20448 is the cis isomer of A-419259 (HY-15764)[1][2].
Target Antigen
Src; Tie; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/rk-20448.html
Purity
99.38
Solubility
DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
NC1=C(C2=NC=N1)C(C3=CC=C(C=C3)OC4=CC=CC=C4)=CN2[C@H]5CC[C@H](CC5)N6CCN(CC6)C
Molecular Weight
482.62
References & Citations
[1]Saito Y, et al. A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo. Sci Transl Med. 2013 Apr 17;5(181):181ra52.|[2]Almoyad MAA, et al. Hematopoietic cell kinase as a nexus for drug repurposing: implications for cancer and HIV therapy. J Biomol Struct Dyn. 2024 Mar 26:1-11.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-118105/RK-20448-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-118105/RK-20448-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
479501-40-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS966479-01 0.05 mg (E-Coli)
Recombinant Human Retinoblastoma-like protein 1 (RBL1) , partial
Ask
View Details